New Delhi [India], September 27: In a significant development for India's animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA).
A day after the Indian Council of Medical Research debunked claims of the Corona vaccine being responsible for the rising death cases among the youth, a panel of expert doctors from the All India Institute of Medical Sciences addressed the issue.
The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India's indigenous tetravalent dengue vaccine, DengiAll, developed by Panac
The Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major Bharat Biotech International's proposal to conduct the Phase II clinical trial of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogen
Union Health Minister Mansukh Mandaviya on Saturday addressed the Global Vaccine Research Collaborative Discussion on Vaccine Research and Development, a G20 co-branded event in Telangana's Hyderabad.
Two companies are conducting trials to develop dengue vaccine, Director General, Indian Council of Medical Research Dr Rajeev Bahl told ANI on Tuesday.
Highlighting the country's stride in pharma and biotechnology sector, Union Minister Jitendra Singh on Sunday said the Indian vaccine market is expected to reach a valuation of Rs 252 billion by 2025.
White House COVID-19 Response Coordinator Dr Ashish Jha called India a major exporter of vaccines in the world because of its incredible manufacturing capacity.
New Delhi [India], August 9 (ANI): The Union Government is considering giving its final approval to Corbevax's heterologous COVID-19 booster for 'Restricted Use in Emergency Situation' soon, sources said.
New Delhi [India], June 28 (ANI): The Subject Expert Committee (SEC) in a meeting held on Friday recommended Emergency Use Authorisation (EUA) for India's first mRNA COVID-19 vaccine, sources told ANI on Tuesday.